An open-labeled phase II trial of docetaxel in combination with cisplatin as first-line cytotoxic therapy for anthracycline-naive patients with metastatic breast cancer

2007 ◽  
Vol 18 (10) ◽  
pp. 1213-1219 ◽  
Author(s):  
Yung-Chang Lin ◽  
Hsien-Kun Chang ◽  
Wen-Chi Shen ◽  
Jen-Shi Chen ◽  
Hung-Ming Wang
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Cytotoxic Therapy ◽  
First Line

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

2002 ◽  
Vol 7 (5) ◽  
pp. 410-417 ◽  
Author(s):  
Mohammad Jahanzeb ◽  
Joanne E. Mortimer ◽  
Furhan Yunus ◽  
David H. Irwin ◽  
James Speyer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II trial of gefitinib combined with docetaxel as first-line therapy in patients with metastatic breast cancer

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3080-3080 ◽  
Author(s):  
F. Ciardiello ◽  
T. Troiani ◽  
F. Caputo ◽  
M. de Laurentiis ◽  
G. Tortora ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer

2010 ◽  
Vol 28 (9) ◽  
pp. 925-931 ◽  
Author(s):  
Denise A. Yardley ◽  
Michael McCleod ◽  
Fred Schreiber ◽  
Patrick Murphy ◽  
Jeffrey Patton ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document